Financial China
China Life - in the balance
- Published 20 Aug 2009
The insurance behemoth looks to be opting for short-term revenue declines to achieve longer-term stability.
China Life (2628:HKG) is the country's insurance behemoth, with 102m individual and group life insurance policies, annuity contracts and long-term health insurance policies at the end of the December 2008. But results haven't been wonderful of late.
Login
If you are already an subscriber, please log in below.
China Confidential Funds
China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.
Other Articles on this Issue
-
The Big Call
A local financial time bomb
-
Consumer China
Pharmaceuticals - a healthy course
Sinovac and swine flu
Sinopharm - a new contender
Simcere – not immune
Tongrentang – TCM bellwether
-
Forbidden City
Iron and awe
-
Financial China
Insurance - a structural play
Ping An - not so tranquil
-
Funds Data
China zeal wavers
-
Postcard From No 528
Wobbling on the liquidity high wire
-
Capital Intensive China
Developers defy doomsayers
-
Guest Column
Bright prospects
-
The Best of Chinese Commentators
Inflation, inflation, inflation
Sovereign wealth
-
Editor's View
A moment of truth
- View issue
v4.0.2.13 running on ftbwebw-sun-02-z1
